Transaction in Own Shares

Foresight Solar Fund Limited
17 May 2023
 

17 May 2023

 

Foresight Solar Fund Limited

(the "Company" or "Foresight Solar")

 

Transaction in own shares

 

The Company announces that on 17 May 2023 it purchased the following ordinary shares (the "ordinary shares") on the London Stock Exchange through the Company's broker Jefferies International Limited ("Jefferies"). 

 

London Stock Exchange (XLON)

Number of ordinary shares purchased

100,000

Highest price paid (per ordinary share)

110.40p

Lowest price paid (per ordinary share)

110.40p

Volume weighted average price paid (per ordinary share)

110.40p

 

The repurchased shares will be held in Treasury.

The purchases form part of the Company's share buyback programme announced on 4 May 2023.

Following settlement of the above purchases, the Company's total issued share capital will comprise of 609,958,720 ordinary shares. 

The total voting rights figure 608,997,668 may be used by shareholders for the calculations by which they will determine if they are required to notify their major interest in, or a change to their major interest in, the company under the FCA's Disclosure Guidance and Transparency Rules.

 

Foresight Group

Matheus Fierro (InstitutionalIR@ForesightGroup.eu)

+44 (0)20 3911 2318

 

 

Jefferies International Limited
Gaudi Le Roux
William Brown
Harry Randall

+44 (0)20 7029 8000

 

 

Citigate Dewe Rogerson              
Toby Moore
Lucy Gibbs

+44 (0)20 7638 9571

 



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings